Clinical Trial · NCT00003763

Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer

Overview

RATIONALE: Diagnostic procedures using the drug radiolabeled folic acid and imaging may be effective in detecting ovarian cancer. PURPOSE: Diagnostic trial to study the effectiveness of radiolabeled folic acid plus imaging in detecting ovarian cancer.

Sponsor

Endocyte

Phase

N/A

Contacts

David M. Gershenson, MD (STUDY_CHAIR)

ClinicalTrials.gov

NCT00003763